T-Reg
Showing 26 - 50 of 8,883
Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Completed
- Ulcerative Colitis
-
Calgary, Alberta, Canada
- +22 more
Jan 22, 2021
Chronicrhinosinusitis Without Nasalpolyps, Sinusitis, Chronic Sinusitis Trial in Worldwide (Dupilumab SAR231893, Placebo)
Recruiting
- Chronicrhinosinusitis Without Nasalpolyps
- +4 more
- Dupilumab SAR231893
- Placebo
-
Roseville, California
- +49 more
May 3, 2022
Kidney Failure, Kidney Transplant Trial in Boston (T Regulatory Cell Infusion)
Completed
- Kidney Failure, Kidney Transplant
- T Regulatory Cell Infusion
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2021
Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)
Recruiting
- Multiple Myeloma
-
Anchorage, Alaska
- +698 more
Jan 24, 2023
Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)
Completed
- Type2 Diabetes Mellitus
- Empagliflozin
- Placebo Oral Tablet
-
Herlev, DenmarkHerlev og Gentofte Hospital
Aug 17, 2022
Neuroendocrine Tumors Trial in Napoli (Octreotide Acetate)
Completed
- Neuroendocrine Tumors
- Octreotide Acetate
-
Napoli, ItalyIstitute Nazionale Tumori - Fondazione G. Pascale
Sep 9, 2020
Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))
Active, not recruiting
- Neuromyelitis Optica Spectrum Disorder
- satralizumab
- +3 more
-
Birmingham, Alabama
- +52 more
Mar 16, 2022
The Temporal Cellular Landscape of Adaptive Immune System in
Recruiting
- Stroke, Acute
-
Amsterdam, Noord-Holland, NetherlandsAcademic University Medical Center Amsterdam
Apr 16, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +6 more
- Biopsy
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Systemic Sclerosis Trial (Autologous Regulatory ?-cells, Standard treatment according to the clinical protocols)
Not yet recruiting
- Systemic Sclerosis
- Autologous Regulatory ΠΆ-cells
- Standard treatment according to the clinical protocols
- (no location specified)
Jan 25, 2022
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento
Recruiting
- Advanced Colorectal Carcinoma
- +15 more
- Fermented Wheat Germ Extract
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jul 26, 2023
Hemophilia A Trial in Worldwide (PEGylated Recombinant Factor VIII, ITI)
Recruiting
- Hemophilia A
- PEGylated Recombinant Factor VIII
- ITI
-
Phoenix, Arizona
- +91 more
Jul 30, 2021
Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)
Completed
- Leukemia
- Lymphoma
- Rituximab
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2021
Non Small Cell Lung Cancer Trial in Los Angeles (Apricoxib)
Terminated
- Non Small Cell Lung Cancer
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 21, 2020
Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +4 more
- Aldesleukin
- +10 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2023
Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory
Recruiting
- Myeloid Leukemia, Chronic
- +8 more
- Conventional T cells (Tcon) and Regulatory T cells (Treg)
-
Palo Alto, CaliforniaStanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021
Rectal Cancer Trial in Australia, New Zealand (TG02-treatment, Pembrolizumab)
Chronic Pain, Neuropathic Pain, Complex Regional Pain Syndromes Trial (Stellate Ganglion Block (SGB), Thoracic Sympathetic
Not yet recruiting
- Chronic Pain
- +4 more
- Stellate Ganglion Block (SGB)
- Thoracic Sympathetic Ganglion Block (TSGB)
- (no location specified)
Nov 8, 2023
GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose
Terminated
- Graft Versus Host Disease
- Cyclophosphamide and Sirolimus
- +3 more
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022
Noninvasive Monitoring of Cerebral Blood Flow Autoregulation
Completed
- Intracranial Pressure Increase
- Cerebral Edema
-
New Orleans, LouisianaOchsner Health System
Dec 8, 2021
Venous Thromboembolism, Secondary Prevention Trial in Worldwide (dabigatran etexilate)
Completed
- Venous Thromboembolism
- Secondary Prevention
- dabigatran etexilate
-
Sacramento, California
- +61 more
May 29, 2020
HIV-1-infection Trial (FMT capsules, Placebo capsules)
Not yet recruiting
- HIV-1-infection
- FMT capsules
- Placebo capsules
- (no location specified)
Aug 31, 2023